Copper‐64/61 and iodine‐125‐labeled dota‐DTYR¹‐octreotate: A new somatostatin analog for labeling with metals and halogens

Publisher Website

1 May 2001

journal article
research article
Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals

Vol. 44 (S1) , S948-S950
https://doi.org/10.1002/jlcr.25804401333

Abstract

No abstract available

Keywords

This publication has 4 references indexed in Scilit:

In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. a new somatostatin analog with improved target tissue uptake
Nuclear Medicine and Biology, 1999
Comparison of Four ⁶⁴Cu-Labeled Somatostatin Analogues in Vitro and in a Tumor-Bearing Rat Model: Evaluation of New Derivatives for Positron Emission Tomography Imaging and Targeted Radiotherapy
Journal of Medicinal Chemistry, 1999
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy
International Journal of Cancer, 1998
Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide
European Journal of Nuclear Medicine and Molecular Imaging, 1993